Geron - 9 Year Dividend History | GERN
Historical dividend payout and yield for Geron (GERN) since 2016. The current TTM dividend payout for Geron (GERN) as of January 17, 2025 is $0.00. The current dividend yield for Geron as of January 17, 2025 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$1.747B |
$0.000B |
|
Geron is a late-stage clinical biopharmaceutical company focused on the development and potential commercialization of a first-in-class telomerase inhibitor, imetelstat, in hematologic malignancies. The Company currently is conducting two Phase 3 clinical trials: IMerge in lower risk myelodysplastic syndromes and IMpactMF in refractory myelofibrosis.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
